Antiphospholipid syndrome in pregnancy - Animal models and clinical implications

Y. Shoenfeld, Y. Sherer, M. Blank

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

The antiphospholipid (APS) syndrome frequently includes severe pregnancy complications such as fetal wastage and recurrent spontaneous abortions. Animal models for APS in pregnancy can provide both an understanding of the pathogenic mechanisms of anti-phospholipid antibodies (aPL), and aid in the evaluation of various therapeutic modalities in APS. Animal models for APS include both spontaneously developed diseases, as is the case for secondary APS in mice with another autoimmune disease, and induced models of APS. The latter includes either passive induction of disease by antibodies infusion, or active induction via manipulation of the idiotypic network. This article summarizes the literature reports of animal models of APS in pregnancy, deal with the various possible mechanisms of action of aPL in pregnancy, and discuss the treatment options of women having pregnancy complications of APS.

Original languageEnglish
Pages (from-to)33-36
Number of pages4
JournalScandinavian Journal of Rheumatology, Supplement
Volume27
Issue number107
DOIs
StatePublished - 1 Jan 1998

Fingerprint

Dive into the research topics of 'Antiphospholipid syndrome in pregnancy - Animal models and clinical implications'. Together they form a unique fingerprint.

Cite this